Dyne Therapeutics Stock (NASDAQ: DYN) stock price, news, charts, stock research, profile.
Open | $25.220 |
Close | - |
Volume / Avg. | 355.786K / 1.403M |
Day Range | 24.830 - 26.330 |
52 Wk Range | 6.400 - 30.269 |
Market Cap | $2.143B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 11.52% |
Days to Cover | 5.37 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Dyne Therapeutics (NASDAQ: DYN) through any online brokerage.
Other companies in Dyne Therapeutics’s space includes: Avidity Biosciences (NASDAQ:RNA), MoonLake (NASDAQ:MLTX), Syndax Pharmaceuticals (NASDAQ:SNDX), Fusion Pharmaceuticals (NASDAQ:FUSN) and TG Therapeutics (NASDAQ:TGTX).
The latest price target for Dyne Therapeutics (NASDAQ: DYN) was reported by Oppenheimer on Tuesday, March 26, 2024. The analyst firm set a price target for 47.00 expecting DYN to rise to within 12 months (a possible 81.26% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Dyne Therapeutics (NASDAQ: DYN) is $25.93 last updated Today at April 23, 2024 at 12:43 PM EDT.
There are no upcoming dividends for Dyne Therapeutics.
Dyne Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Dyne Therapeutics.
Dyne Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.